Michael Scolaro

Michael Scolaro

Aug 22, 2017

Group 6 Copy 33
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Assessing Guadalupe Fur Seal Health and Ecology

    A multidisciplinary team of researchers will assess the health of Guadalupe fur seal pups and adults by...

    Bridging International Borders to Fight Re-emerging Plague in Madagascar

    The Plague is considered one of the most successful infectious agents in history and at one point killed...

    Do Pacific Northwest marine mammals carry antibiotic-resistant bacteria from land animals?

    Antibiotic resistance, a global concern, is a significant health issue of animals and humans. Resistant...

    Backer Badge Funded